search
Back to results

Abnormal Movements, Cerebellum and Sensorimotor : Oculomotor Study (MOUVADOC)

Primary Purpose

Healthy, Dystonia, Parkinson Disease

Status
Completed
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Tracking eye movement
Tracking eye movement under deep brain stimulation
Sponsored by
Institut National de la Santé Et de la Recherche Médicale, France
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Healthy focused on measuring Dystonia, Cerebellar, ocular movements, DYT 11, sensorimotor integration

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion criteria:

  • Age ≥18 years
  • -normal cognitive functions (>24y)
  • Normal clinical examination of ocular mobility, visualization of the target
  • No drug potentially able to modify and to influence the data: anti-depressants, neuroleptics, anti-emetics, amphetamines, anti myoclonic/dystonic drugs, alcohol, dopaminergic drug, antiepileptic.
  • Dystonia or essential tremor or Parkinson: diagnostic made by a neurologist
  • For DYT11: mutation in SGCE gene.
  • For dystonia: No secondary dystonia
  • For Parkinson : UPDRS<28
  • No other neurological disorder

For the patient having deep brain stimulation:

  • Duration of stimulation> 6 months
  • Cerebral imagery post operation made
  • Stimulation parameter stable since 3 months at least.
  • Usual stop of the stimulation during the night

Exclusion criteria:

  • Uncontrollable medical problems not related to M-D
  • Current active psychiatric disorder
  • Intake during the last 3 days of drugs potentially able to modify and to influence the data: anti-depressants, neuroleptics, anti-emetics, amphetamines, anti myoclonic/dystonic drugs, alcohol, dopaminergic drug
  • Subjects legally protected.
  • Subjects who are not enrolled at social security.

Sites / Locations

  • : Fédération des Maladies du Système Nerveux

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm Type

Other

Experimental

Experimental

Experimental

Arm Label

Healthy

Dystonia

Parkinson

Essential tremor

Arm Description

Healthy volunteers

patients with Primary Dystonia

patients with Parkinson's disease

patients with essential tremor with or without deep brain stimulation

Outcomes

Primary Outcome Measures

Saccadic adaptation
Saccadic adaptation, evaluated as the percentage of changes in the mean saccade amplitude between the pre-test and post-test.
Characteristics of the saccade
latency, velocity, duration of the saccade

Secondary Outcome Measures

Full Information

First Posted
May 18, 2011
Last Updated
February 23, 2016
Sponsor
Institut National de la Santé Et de la Recherche Médicale, France
search

1. Study Identification

Unique Protocol Identification Number
NCT01495897
Brief Title
Abnormal Movements, Cerebellum and Sensorimotor : Oculomotor Study
Acronym
MOUVADOC
Official Title
Adaptation Sensorimotrice, Cervelet et Mouvements Anormaux: Projet d'étude Oculomotrice
Study Type
Interventional

2. Study Status

Record Verification Date
February 2016
Overall Recruitment Status
Completed
Study Start Date
March 2011 (undefined)
Primary Completion Date
March 2014 (Actual)
Study Completion Date
March 2014 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Institut National de la Santé Et de la Recherche Médicale, France

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Dystonia is a movement disorder characterized by involuntary, sustained, often repetitive muscle contractions of opposite muscles that lead to abnormal twisting movements or odd postures. Essential tremor is a slowly progressive neurologic disorder characterized by the appearance of a tremor during the voluntary movement. The pathophysiology of dystonia or essential tremor is not fully elucidated. Dystonia and essential tremor are associated with dysfunction of the sensorimotor basal ganglia-cortical network and involvement of the cerebellum and cerebellar pathways has also been recently suggested. The investigators propose to study 30 patients having a primary dystonia (15 DYT11 genetically documented), 15 patients having an essential tremor without deep brain stimulation and 15 patients having an essential tremor with deep brain stimulation.A group of 30 healthy volunteers will be recruited and tested according to the same modalities. They will be paired in sex and age. 30 patients having a Parkinson disease will be also tested. Eye position will be sampled with a video-based monocular eye tracker (SMI, Germany) before and immediately after an adaptation task. Saccade adaptation is evaluated as the percentage change in the mean saccade amplitude between pre-test and post-test. Expected results: no or fewer alteration of the performance to the adaptation task in the Parkinson group than in the Essential Tremor group/ dystonia group. abnormal reactive saccade backward adaptation in the Dystonia group and Essential Tremor group, providing further neurophysiological evidence of cerebellar dysfunction.
Detailed Description
Dystonia is a movement disorder characterized by involuntary, sustained, often repetitive muscle contractions of opposite muscles that lead to abnormal twisting movements or odd postures. Essential tremor is a slowly progressive neurologic disorder characterized by the appearance of a tremor during the voluntary movement. High frequency stimulation of the ventral intermedius nucleus (Vim) of the thalamus, relay for the cerebellar output, is successfully used for the treatment of severe essential tremor. It occasionally induces adverse event such as balance disorders or cerebellar symptoms. The pathophysiology of dystonia or essential tremor is not fully elucidated. Dystonia and essential tremor are associated with dysfunction of the sensorimotor basal ganglia-cortical network and involvement of the cerebellum and cerebellar pathways has also been recently suggested. It seems that dystonia and essential tremor could be the result of basal ganglia or cerebellar dysfunction, or from dysfunction of structures controlled at the same time by the cerebellum and the basal ganglia. methodology: We propose to study 30 patients having a primary dystonia (15 DYT11 genetically documented), 15 patients having an essential tremor without deep brain stimulation and 15 patients having an essential tremor with deep brain stimulation. A group of 30 healthy volunteers will be recruited and tested according to the same modalities. They will be paired in sex and age. 30 patients having a Parkinson disease will be also tested. The subjects will be seated in darkness facing a screen located 60 cm before their eyes, their chin on a chin strap and their forehead placed against a frontal support. Eye position is sampled at 500 Hz with a video-based monocular eye tracker (SMI, Germany). Each recording session start with a calibration test in which the subjects looked at nine consecutive targets covering the entire visual field, as used during the oculomotor paradigms: four experimental conditions: a visually guided saccade task, a pre-test, a backward adaptation task, and a post-test. The pre-test and post-test (40 trials each) are performed before and immediately after the backward adaptation task, in the same conditions, except that the target was extinguished when the velocity threshold (150°/s for 10 ms) is reached, instead of jumping to a new location. This avoided any post-saccadic visual feedback that would counteract the adaptive mechanism. Saccade adaptation is evaluated as the percentage change in the mean saccade amplitude between the pre-test and post-test. Expected results: no or fewer alteration of the performance to the adaptation task in the Parkinson group than in the Essential Tremor group/ dystonia group. abnormal reactive saccade backward adaptation in the Dystonia group and Essential Tremor group, providing further neurophysiological evidence of cerebellar dysfunction.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Healthy, Dystonia, Parkinson Disease
Keywords
Dystonia, Cerebellar, ocular movements, DYT 11, sensorimotor integration

7. Study Design

Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
14 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Healthy
Arm Type
Other
Arm Description
Healthy volunteers
Arm Title
Dystonia
Arm Type
Experimental
Arm Description
patients with Primary Dystonia
Arm Title
Parkinson
Arm Type
Experimental
Arm Description
patients with Parkinson's disease
Arm Title
Essential tremor
Arm Type
Experimental
Arm Description
patients with essential tremor with or without deep brain stimulation
Intervention Type
Device
Intervention Name(s)
Tracking eye movement
Intervention Description
Device: studying Saccadic eye movements with a video eye tracker: The subjects are seated in darkness facing a screen located 60 cm before their eyes, their chin on a chin strap and their forehead placed against a frontal support. Eye position is sampled at 500 Hz with a video-based monocular eye tracker (SMI, Germany). Each recording session start with a calibration test in which the subjects looked at nine consecutive targets covering the entire visual field, as used during the oculomotor paradigms: four experimental conditions: a visually guided saccade task, a pre-test, a backward adaptation task, and a post-test. The pre-test and post-test (40 trials each) are performed before and immediately after the backward adaptation task, in the same conditions, except that the target was extinguished when the velocity threshold (150°/s for 10 ms) is reached, instead of jumping to a new location.
Intervention Type
Device
Intervention Name(s)
Tracking eye movement under deep brain stimulation
Intervention Description
Device: studying Saccadic eye movements with a video eye tracker. If the patient has deep brain stimulation, recording will be made in the morning, before the usual morning start of the deep brain stimulation.
Primary Outcome Measure Information:
Title
Saccadic adaptation
Description
Saccadic adaptation, evaluated as the percentage of changes in the mean saccade amplitude between the pre-test and post-test.
Time Frame
between the pre-test and post-test, maximum 4 hours
Title
Characteristics of the saccade
Description
latency, velocity, duration of the saccade
Time Frame
measured during the analysis of the recorded session, maximum 4 hours

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion criteria: Age ≥18 years -normal cognitive functions (>24y) Normal clinical examination of ocular mobility, visualization of the target No drug potentially able to modify and to influence the data: anti-depressants, neuroleptics, anti-emetics, amphetamines, anti myoclonic/dystonic drugs, alcohol, dopaminergic drug, antiepileptic. Dystonia or essential tremor or Parkinson: diagnostic made by a neurologist For DYT11: mutation in SGCE gene. For dystonia: No secondary dystonia For Parkinson : UPDRS<28 No other neurological disorder For the patient having deep brain stimulation: Duration of stimulation> 6 months Cerebral imagery post operation made Stimulation parameter stable since 3 months at least. Usual stop of the stimulation during the night Exclusion criteria: Uncontrollable medical problems not related to M-D Current active psychiatric disorder Intake during the last 3 days of drugs potentially able to modify and to influence the data: anti-depressants, neuroleptics, anti-emetics, amphetamines, anti myoclonic/dystonic drugs, alcohol, dopaminergic drug Subjects legally protected. Subjects who are not enrolled at social security.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Emmanuel Flamand-Roze, MD, PhD
Organizational Affiliation
Institut National de la Santé Et de la Recherche Médicale, France
Official's Role
Study Director
Facility Information:
Facility Name
: Fédération des Maladies du Système Nerveux
City
Paris
ZIP/Postal Code
75013
Country
France

12. IPD Sharing Statement

Learn more about this trial

Abnormal Movements, Cerebellum and Sensorimotor : Oculomotor Study

We'll reach out to this number within 24 hrs